Erasmus Molecular Assays to Streamline Influenza Testing
Scientists from Erasmus University in the Netherlands have designed and evaluated a set of molecular assays that they say are ...
Scientists from Erasmus University in the Netherlands have designed and evaluated a set of molecular assays that they say are ...
The Department of Health and Human Services (HHS) last week announced a $1.8 million contract award to support development of ...
Becton, Dickinson and Company has been awarded a $1,798,090 contract for advanced development of a new point-of-care diagnostic test combining ...
Illnesses caused by many of the world's most deadly viruses cannot be effectively treated with existing drugs or vaccines. A ...
SIGA Technologies this week announced the first of a series of deliveries of its proprietary smallpox antiviral drug, Arestvyr (formerly ...
Scientists from Australia’s Commonwealth Scientific and Industrial Research Organization (CSIRO) have helped to design a new drug to safeguard against epidemic ...
Research led by a team from the University of California, Los Angeles (UCLA) has identified a protein with broad virus-fighting ...
Three on-going clinical trials sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) Influenza Research Collaboration, a clinical ...
A wide consortium of investigators led by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has published findings ...
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness & Response (ASPR) this week awarded ...
AstraZeneca and the Broad Institute in Cambridge, Massachusetts this week announced a two-year collaboration to identify new chemical compounds targeting bacterial and viral infections ...
Researchers in Wales have identified properties in a common cup of tea that could help deactivate some bioterror agents and ...
National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) in support of the ...
The Biomedical Advanced Research and Development Authority (BARDA) has formally released BARDA-CBRN-BAA-12-100-SOL-00011 for “Advanced Research and Development of Chemical, Biological, Radiological, ...
Last week a Delaware Court of Chancery issued its final judgment in litigation spanning over 5 years brought by PharmAthene, ...
Army scientists and industry collaborators have successfully protected laboratory animals from lethal hantavirus disease using a novel approach that combines DNA ...
National Institute of Allergy and Infectious Diseases (NIAID) has awarded an $8.1M biodefense grant to develop new drugs to treat ...
Australian drug development company Biota announced on Monday that it will be moving to the United States and merging with ...
In a study published this week in the Journal of Virology, University of British Columbia researchers identified a number of ...
MediVector, Inc., a privately held drug development company in Boston, is being awarded a $138,500,000 contract under a DoD Joint ...